Dow Up 0.11% Nasdaq Up 0.50%

Myriad Genetics Inc. (MYGN)

-NasdaqGS
36.19 Up 0.18(0.50%) 4:00PM EDT
|After Hours : 36.19 Up 0.00 (0.01%) 4:44PM EDT
Prev Close:36.01
Open:36.01
Bid:34.01 x 100
Ask:36.85 x 200
1y Target Est:38.85
Beta:0.93
Earnings Date:Nov 3 - Nov 7 (Est.)
Day's Range:36.01 - 36.42
52wk Range:20.02 - 42.50
Volume:370,476
Avg Vol (3m):881,092
Market Cap:2.63B
P/E (ttm):15.35
EPS (ttm):2.36
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
MYGNUp 0.50%2.63B
ABTDown 0.26%63.52B

Key Statistics

Forward P/E (1 yr):16.38
P/S (ttm):3.37
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Jun-15) :1.94
Quarterly EPS Est (Sep-14) :0.41
Mean Recommendation*:2.7
PEG Ratio (5 yr expected):1.21

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Myriad Genetics, Inc., a molecular diagnostic company, focuses on the development and marketing of predictive medicine, personalized medicine, and prognostic medicine tests in the United States and internationally. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback